170 related articles for article (PubMed ID: 24012809)
1. UDP-galactopyranose mutases from Leishmania species that cause visceral and cutaneous leishmaniasis.
Fonseca IO; Kizjakina K; Sobrado P
Arch Biochem Biophys; 2013 Oct; 538(2):103-10. PubMed ID: 24012809
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of functional Leishmania major virulence factor UDP-galactopyranose mutase.
Oppenheimer M; Valenciano AL; Sobrado P
Biochem Biophys Res Commun; 2011 Apr; 407(3):552-6. PubMed ID: 21419104
[TBL] [Abstract][Full Text] [Related]
3. Chemical mechanism of UDP-galactopyranose mutase from Trypanosoma cruzi: a potential drug target against Chagas' disease.
Oppenheimer M; Valenciano AL; Kizjakina K; Qi J; Sobrado P
PLoS One; 2012; 7(3):e32918. PubMed ID: 22448231
[TBL] [Abstract][Full Text] [Related]
4. Structural insight into the unique substrate binding mechanism and flavin redox state of UDP-galactopyranose mutase from Aspergillus fumigatus.
van Straaten KE; Routier FH; Sanders DA
J Biol Chem; 2012 Mar; 287(14):10780-90. PubMed ID: 22334662
[TBL] [Abstract][Full Text] [Related]
5. Targeting UDP-galactopyranose mutases from eukaryotic human pathogens.
Kizjakina K; Tanner JJ; Sobrado P
Curr Pharm Des; 2013; 19(14):2561-73. PubMed ID: 23116395
[TBL] [Abstract][Full Text] [Related]
6. Structure, mechanism, and dynamics of UDP-galactopyranose mutase.
Tanner JJ; Boechi L; Andrew McCammon J; Sobrado P
Arch Biochem Biophys; 2014 Feb; 544():128-41. PubMed ID: 24096172
[TBL] [Abstract][Full Text] [Related]
7. Characterization of recombinant UDP-galactopyranose mutase from Aspergillus fumigatus.
Oppenheimer M; Poulin MB; Lowary TL; Helm RF; Sobrado P
Arch Biochem Biophys; 2010 Oct; 502(1):31-8. PubMed ID: 20615386
[TBL] [Abstract][Full Text] [Related]
8. A unique catalytic mechanism for UDP-galactopyranose mutase.
Soltero-Higgin M; Carlson EE; Gruber TD; Kiessling LL
Nat Struct Mol Biol; 2004 Jun; 11(6):539-43. PubMed ID: 15133501
[TBL] [Abstract][Full Text] [Related]
9. Contributions of unique active site residues of eukaryotic UDP-galactopyranose mutases to substrate recognition and active site dynamics.
Da Fonseca I; Qureshi IA; Mehra-Chaudhary R; Kizjakina K; Tanner JJ; Sobrado P
Biochemistry; 2014 Dec; 53(49):7794-804. PubMed ID: 25412209
[TBL] [Abstract][Full Text] [Related]
10. Substrate directs enzyme dynamics by bridging distal sites: UDP-galactopyranose mutase.
Yao X; Bleile DW; Yuan Y; Chao J; Sarathy KP; Sanders DA; Pinto BM; O'Neill MA
Proteins; 2009 Mar; 74(4):972-9. PubMed ID: 18767162
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel inhibitors against UDP-galactopyranose mutase to combat leishmaniasis.
Kashif M; Tabrez S; Husein A; Arish M; Kalaiarasan P; Manna PP; Subbarao N; Akhter Y; Rub A
J Cell Biochem; 2018 Mar; 119(3):2653-2665. PubMed ID: 29058760
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures and small-angle x-ray scattering analysis of UDP-galactopyranose mutase from the pathogenic fungus Aspergillus fumigatus.
Dhatwalia R; Singh H; Oppenheimer M; Karr DB; Nix JC; Sobrado P; Tanner JJ
J Biol Chem; 2012 Mar; 287(12):9041-51. PubMed ID: 22294687
[TBL] [Abstract][Full Text] [Related]
13. UDP-galactopyranose mutase in nematodes.
Wesener DA; May JF; Huffman EM; Kiessling LL
Biochemistry; 2013 Jun; 52(25):4391-8. PubMed ID: 23697711
[TBL] [Abstract][Full Text] [Related]
14. Site-directed mutagenesis of UDP-galactopyranose mutase reveals a critical role for the active-site, conserved arginine residues.
Chad JM; Sarathy KP; Gruber TD; Addala E; Kiessling LL; Sanders DA
Biochemistry; 2007 Jun; 46(23):6723-32. PubMed ID: 17511471
[TBL] [Abstract][Full Text] [Related]
15. UDP-galactopyranose mutase, a potential drug target against human pathogenic nematode Brugia malayi.
Misra S; Valicherla GR; Mohd Shahab ; Gupta J; Gayen JR; Misra-Bhattacharya S
Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27465638
[TBL] [Abstract][Full Text] [Related]
16. Chemoenzymatic synthesis, inhibition studies, and X-ray crystallographic analysis of the phosphono analog of UDP-Galp as an inhibitor and mechanistic probe for UDP-galactopyranose mutase.
Partha SK; Sadeghi-Khomami A; Slowski K; Kotake T; Thomas NR; Jakeman DL; Sanders DA
J Mol Biol; 2010 Nov; 403(4):578-90. PubMed ID: 20850454
[TBL] [Abstract][Full Text] [Related]
17. Ligand binding and substrate discrimination by UDP-galactopyranose mutase.
Gruber TD; Borrok MJ; Westler WM; Forest KT; Kiessling LL
J Mol Biol; 2009 Aug; 391(2):327-40. PubMed ID: 19500588
[TBL] [Abstract][Full Text] [Related]
18. Identification and partial characterization of two eukaryotic UDP-galactopyranose mutases.
Bakker H; Kleczka B; Gerardy-Schahn R; Routier FH
Biol Chem; 2005 Jul; 386(7):657-61. PubMed ID: 16207086
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of ligand binding to UDP-galactopyranose mutase from Mycobacterium tuberculosis using substrate and tetrafluorinated substrate analogues.
van Straaten KE; Kuttiyatveetil JR; Sevrain CM; Villaume SA; Jiménez-Barbero J; Linclau B; Vincent SP; Sanders DA
J Am Chem Soc; 2015 Jan; 137(3):1230-44. PubMed ID: 25562380
[TBL] [Abstract][Full Text] [Related]
20. Identification of the NAD(P)H binding site of eukaryotic UDP-galactopyranose mutase.
Dhatwalia R; Singh H; Solano LM; Oppenheimer M; Robinson RM; Ellerbrock JF; Sobrado P; Tanner JJ
J Am Chem Soc; 2012 Oct; 134(43):18132-8. PubMed ID: 23036087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
